Home›Regadenoson

Regadenoson

Also known as: Regadenoson

Adenosine Receptor AgonistAdenosine Receptor Agonists

Route: Intravenous

7 interactions on record

Regadenoson has 7 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Aspirin And Extended - Release Dipyridamole, Asprin And Extended-Release Dipyridamole, Dipyridamole. Patients taking Regadenoson should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 7
Major: 3
Moderate: 4

Major (3)

Regadenoson + Aspirin And Extended - Release Dipyridamole— Dipyridamole increases cardiovascular effects of regadenoson. Risk of cardiovascular side effects may be increased durin…
Regadenoson + Asprin And Extended-Release Dipyridamole— Dipyridamole increases cardiovascular effects of regadenoson. Risk of cardiovascular side effects may be increased if di…
Regadenoson + Dipyridamole— Dipyridamole increases cardiovascular effects of regadenoson (adenosine A2A-receptor agonist). Risk of cardiovascular si…

Moderate (4)

Regadenoson + Aminophylline— Methylxanthine that interferes with the vasodilation activity of regadenoson. Patients should avoid for at least 12 hour…
Regadenoson + Aspirin And Dipyridamole— Dipyridamole increases cardiovascular effects of regadenoson, an adenosine A2A-receptor agonist. Risk of cardiovascular …
Regadenoson + Caffeine— Methylxanthine that interferes with the vasodilation activity of regadenoson. Patients should avoid consumption for at l…
Regadenoson + Theophylline— Methylxanthine that interferes with the vasodilation activity of regadenoson. Patients should avoid consumption for at l…

Regadenoson + Aspirin And Extended - Release Dipyridamole⚠️Major

Dipyridamole increases cardiovascular effects of regadenoson. Risk of cardiovascular side effects may be increased during stress testing when dipyridamole is not held 48 hours prior.

Regadenoson + Asprin And Extended-Release Dipyridamole⚠️Major

Dipyridamole increases cardiovascular effects of regadenoson. Risk of cardiovascular side effects may be increased if dipyridamole is not held 48 hours prior to stress testing.

Regadenoson + Dipyridamole⚠️Major

Dipyridamole increases cardiovascular effects of regadenoson (adenosine A2A-receptor agonist). Risk of cardiovascular side effects may be increased during stress testing.

Regadenoson + Aminophylline🟡Moderate

Methylxanthine that interferes with the vasodilation activity of regadenoson. Patients should avoid for at least 12 hours before administration, though it may be used to attenuate severe adverse reactions.

Regadenoson + Aspirin And Dipyridamole🟡Moderate

Dipyridamole increases cardiovascular effects of regadenoson, an adenosine A2A-receptor agonist. Risk of cardiovascular side effects may be increased during testing.

Regadenoson + Caffeine🟡Moderate

Methylxanthine that interferes with the vasodilation activity of regadenoson. Patients should avoid consumption for at least 12 hours before regadenoson administration.

Regadenoson + Theophylline🟡Moderate

Methylxanthine that interferes with the vasodilation activity of regadenoson. Patients should avoid consumption for at least 12 hours before regadenoson administration.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.